Fund+ Establishes ExeVir Bio with VIB and UCB to Accelerate Development of New Treatment Conferring Broad Protection Against Covid-19

Fund+ Establishes ExeVir Bio with…

Fund+ Leads EUR38 Million Series B Financing in Indigo Diabetes NV

Fund+ Leads EUR38 Million Series…

Fund+ Announces Investment in Ona Therapeutics EUR30 Million Series A financing

Fund+ Announces Investment in Ona…

Notable Board Changes

Notable Board Changes Fund+ Appoints…

Job opening at Fund+ / Internship

Job opening Internship Fund+ is…

Job opening at Fund+ / Senior Associate

Job opening Senior Associate Fund+…